Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 392

Results For "US"

7355 News Found

First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl
Policy | August 24, 2023

First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl

Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl


Vice President Jagdeep Dhankar delivers convocation address at the 48th AIIMS convocation
News | August 24, 2023

Vice President Jagdeep Dhankar delivers convocation address at the 48th AIIMS convocation

Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country


Jupiter Life Line Hospitals raised Rs. 123 crore in pre IPO round
News | August 23, 2023

Jupiter Life Line Hospitals raised Rs. 123 crore in pre IPO round

Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO


Briefs: Concord Biotech, Cian Healthcare and Eris Lifesciences
News | August 23, 2023

Briefs: Concord Biotech, Cian Healthcare and Eris Lifesciences

Eris Lifesciences enters into term loan agreement with Citi Bank


Former Bayer Pharma CEO Dieter Weinand joins Coya’s Board of Directors
People | August 22, 2023

Former Bayer Pharma CEO Dieter Weinand joins Coya’s Board of Directors

Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business


LEO Pharma to acquire Timber Pharmaceuticals
News | August 22, 2023

LEO Pharma to acquire Timber Pharmaceuticals

The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million


Shiva Pharmachem files DRHP for its Rs. 900 crore IPO
News | August 22, 2023

Shiva Pharmachem files DRHP for its Rs. 900 crore IPO

The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment


Jiangsu Hengrui Pharmaceuticals gets NMPA approval of oteseconazole Ccapsules
Drug Approval | August 22, 2023

Jiangsu Hengrui Pharmaceuticals gets NMPA approval of oteseconazole Ccapsules

Oteseconazole Capsules were found to be safe and more effective than fluconazole


EMA accepts LEO Pharma’s MAA for delgocitinib cream in chronic hand eczema
Drug Approval | August 21, 2023

EMA accepts LEO Pharma’s MAA for delgocitinib cream in chronic hand eczema

LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment


Dr. Reddy's appoints Sunil Gavaskar as the brand ambassador for its #TensionMatLo campaign
Healthcare | August 21, 2023

Dr. Reddy's appoints Sunil Gavaskar as the brand ambassador for its #TensionMatLo campaign

The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle